Enovis Corporation logo

Enovis Corporation (CFX)

Delisted
5 Apr 2022
NYSE NYSE
$
39. 06
-1.53
-3.77%
$
2.12B Market Cap
- P/E Ratio
- Div Yield
2,953,345 Volume
- Eps
$ 40.59
Previous Close
Investors:
Day Range
38.88 40.67
Year Range
38.88 94.03
Want to track CFX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

CFX Chart

Enovis Corporation Investors

Name Quantity Cost Value Profit ($) Gain (%)
Defender Capital
Defender Capital Defender Capital LLC
49,747.87 $6.56M $1.56M -$5M -76.21%

Enovis Corporation (CFX) FAQ

What does "Delisted" mean?

Enovis Corporation has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

No dividend payments were recorded prior to delisting.

How long did the company pay dividends?

The company did not have a dividend payment history.

Were there any stock splits?

The last recorded stock split occurred on Apr 05, 2022 with a ratio of 1:3.

What was the last known trading price?

The stock last traded at $39.06 on Apr 05, 2022 before being delisted.

Enovis Corporation Profile

Machinery Industry
Industrials Sector
Matthew L. Trerotola CEO
NYSE Exchange
194014106 CUSIP
US Country
15,400 Employees
- Last Dividend
5 Apr 2022 Last Split
- IPO Date

Overview

Colfax Corporation, founded in 1860 and headquartered in Wilmington, Delaware, positions itself as a diversified technology company with a global presence. The company operates through two primary segments: Fabrication Technology and Medical Technology. Across these segments, Colfax provides a wide range of products and services tailored to meet the needs of various industries, including general industry, construction, infrastructure, transportation, energy, renewable energy, and the medical and life sciences markets. By leveraging its technical expertise and global distribution network, Colfax aims to deliver innovative solutions that address complex challenges faced by its customers.

Products and Services

  • Fabrication Technology

    This segment specializes in the formulation, development, manufacturing, and supply of consumable products and equipment essential for cutting, joining, and automated welding, along with gas control equipment. Its product line includes:

    • Welding Consumables: Offers electrodes, cored and solid wires, and fluxes made from a variety of specialty and other materials.
    • Cutting Consumables: Provides electrodes, nozzles, shields, and tips designed for cutting applications.

    Products from the Fabrication Technology segment are marketed mainly under the ESAB brand. These products reach their end-users through independent distributors and direct sales, catering to sectors like general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences.

  • Medical Technology

    This segment focuses on the development, manufacture, and distribution of medical device products that support orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The offerings include:

    • Orthopedic Bracing: Provides both rigid and soft orthopedic braces for patient support and injury recovery.
    • Therapy Products: Offers hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments.
    • Therapeutic Shoes and Inserts: Supplies specialized footwear and inserts for patients suffering from musculoskeletal conditions.
    • Electrical Stimulators: Markets electrical stimulators for pain management and physical therapy products.
    • Reconstructive Joint Products: Offers a suite of products for hip, knee, shoulder, elbow, foot, ankle, and finger reconstruction.

    The Medical Technology segment distributes its products under the DJO brand through independent distributors, healthcare professionals, consumer retail stores, and pharmacies, as well as directly to consumers. These products aim to treat patients with musculoskeletal conditions arising from degenerative diseases, deformities, traumatic events, and sports-related injuries.

Contact Information

Address: 420 National Business Parkway
Phone: 301 323 9000